RE: RNS4 Sep 2020 08:10
Yep mystic Bermuda!!!
RNS Number : 0029Y
Scancell Holdings Plc
04 September 2020
04 September 2020
Scancell Holdings plc
("Scancell" or the "Company")
Director Award of Share Options
Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, announces that on 30 July 2020 it has granted 3,850,000 share options to acquire ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares") to Professor Lindy Durrant and 2,880,000 share options to acquire ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares") to Dr Richard Goodfellow. These share options will expire on 30 July 2023 and replace previously issued share options that expired on 14 July 2020.
The Options have an exercise price of 4.5 pence each (the same price as the expired shares) and will vest twelve months from the date of Grant.